Completed PHASE3 INTERVENTIONAL 3-arm NCT00812422

The Efficacy and Safety of Dexibuprofen Syrup

Multi-center, Randomized, Double Blinded (Double-dummy), Active-Controlled Parallel-group Comparative, Phase 3 Clinical Trial to Assess the Efficacy and Safety of Dexibuprofen Syrup Compared to Ibuprofen Syrup in Patients With Fever of Common Cold (Acute Upper Respiratory Infection)

Sponsor: Inje University

Conditions Fever Respiratory Tract Infection

Interventions Dexibuprofen Ibuprofen

Updated 6 times since 2017 Last updated: Jan 15, 2010 Started: Feb 29, 2008 Primary completion: May 31, 2009 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Fever and Respiratory Tract Infection, this trial is completed. The trial is conducted by Inje University and has accumulated 6 data snapshots since 2008. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Inje University

Data source: Inje University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea